Register Login
Register to leave comments
  • News bot May 7, 2026, 8:42 p.m.

    📋 HALOZYME THERAPEUTICS, INC. (HALO) - Regulatory Update

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:16:24

    Event Type: Regulatory Update

    Event Details:

    HALOZYME THERAPEUTICS, INC. (HALO) Announces Regulatory Update HALOZYME THERAPEUTICS, INC. (HALO) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (HALOZYME THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Atezolizumab Other Phase PHASE1 Cholangiocarcinoma Non-resectable ClinicalTrials.gov
    GEM Other Phase PHASE1 Cholangiocarcinoma Non-resectable ClinicalTrials.gov
    CIS Other Phase PHASE1 Cholangiocarcinoma Non-resectable ClinicalTrials.gov
    PEGPH20 Other Phase PHASE1 Cholangiocarcinoma Non-resectable ClinicalTrials.gov
    Gemcitabine Other Phase PHASE3 Pancreatic Ductal Carcinoma ClinicalTrials.gov
    nab-Paclitaxel Other Phase PHASE3 Pancreatic Ductal Carcinoma ClinicalTrials.gov
    Placebo Other Phase PHASE3 Pancreatic Ductal Carcinoma ClinicalTrials.gov
    Biological: PEGylated Recombinant Human Hyaluronidase (PEGPH20) Other Phase PHASE3 Pancreatic Ductal Carcinoma ClinicalTrials.gov
    Subcutaneous HYLENEX (recombinant human hyaluronidase) and Lactated Ringer's solution Other Phase PHASE4 Dehydration ClinicalTrials.gov
    Ondansetron solution Other Phase PHASE1 Healthy ClinicalTrials.gov
    Zofran ODT Other Phase PHASE1 Healthy ClinicalTrials.gov
    Ondansetron + Hylenex Other Phase PHASE1 Healthy ClinicalTrials.gov
    Ondansetron Other Phase PHASE1 Healthy ClinicalTrials.gov
    Insulin aspart Other Phase PHASE1 Healthy ClinicalTrials.gov
    Insulin glulisine Other Phase PHASE1 Healthy ClinicalTrials.gov
    Insulin lispro Other Phase PHASE1 Healthy ClinicalTrials.gov
    Recombinant human hyaluronidase PH20 (rHuPH20) Other Phase PHASE1 Healthy ClinicalTrials.gov
    Insulin glargine Other Phase PHASE2 Diabetes Mellitus, Type II ClinicalTrials.gov
    Recombinant human hyaluronidase PH20 Other Phase PHASE2 Diabetes Mellitus, Type II ClinicalTrials.gov
    Cohort 4: bococizumab 300 mg + rHuPH20 Other Phase PHASE1 Healthy ClinicalTrials.gov
    Cohort 5: bococizumab 450 mg + rHuPH20 Other Phase PHASE1 Healthy ClinicalTrials.gov
    Cohort 3: bococizumab 300 mg + rHuPH20 Other Phase PHASE1 Healthy ClinicalTrials.gov
    Cohort 2: bococizumab 300 mg Other Phase PHASE1 Healthy ClinicalTrials.gov
    Cohort 1: bococizumab 150 mg + rHuPH20 Other Phase PHASE1 Healthy ClinicalTrials.gov
    Isotonic hydration fluid and recombinant human hyaluronidase Other Phase PHASE4 Dehydration ClinicalTrials.gov
    Oral rehydration fluid Other Phase PHASE4 Dehydration ClinicalTrials.gov
    Precommercial Hylenex recombinant (hyaluronidase human injection) Other Phase PHASE4 Type 1 Diabetes Mellitus ClinicalTrials.gov
    Commercial Hylenex® recombinant (hyaluronidase human injection) Other Phase PHASE4 Type 1 Diabetes Mellitus ClinicalTrials.gov
    Sham injection Other Phase PHASE4 Type 1 Diabetes Mellitus ClinicalTrials.gov
    Rapid Acting insulin with pre-treatment of rHuPH20 Drug Phase PHASE4 Type 1 Diabetes Mellitus ClinicalTrials.gov
    Docetaxel Other Phase PHASE1 Non-small Cell Lung Cancer ClinicalTrials.gov
    PEGylated recombinant human hyaluronidase PH20 Other Phase PHASE1 Non-small Cell Lung Cancer ClinicalTrials.gov
    Pembrolizumab Other Phase PHASE2 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Abraxane Other Phase PHASE2 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Pegvorhyaluronidase alfa Other Phase PHASE2 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Biologic: PEGylated recombinant human hyaluronidase Other Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Biologic: PEGylated recombinant human hyaluronidase (PEGPH20) Other Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Eribulin mesylate Other Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Enoxaparin Other Phase PHASE2 Metastatic Pancreatic Cancer ClinicalTrials.gov
    Dexamethasone Other Phase PHASE2 Metastatic Pancreatic Cancer ClinicalTrials.gov
    CINRYZE with rHuPH20 Other Phase PHASE2 Hereditary Angioedema ClinicalTrials.gov
    5-fluorouracil Other Phase PHASE1 Metastatic Pancreatic Adenocarcinoma ClinicalTrials.gov
    Irinotecan Other Phase PHASE1 Metastatic Pancreatic Adenocarcinoma ClinicalTrials.gov
    Leucovorin Other Phase PHASE1 Metastatic Pancreatic Adenocarcinoma ClinicalTrials.gov
    Oxaliplatin Other Phase PHASE1 Metastatic Pancreatic Adenocarcinoma ClinicalTrials.gov
    5-Fluorouracil (5-FU) Other Phase PHASE1 Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma ClinicalTrials.gov
    Tiragolumab Other Phase PHASE1 Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma ClinicalTrials.gov
    Cisplatin Other Phase PHASE1 Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma ClinicalTrials.gov
    Cobimetinib Other Phase PHASE1 Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma ClinicalTrials.gov
    Linagliptin Other Phase PHASE1 Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma ClinicalTrials.gov
    BL-8040 Other Phase PHASE1 Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma ClinicalTrials.gov
    PEGylated recombinant human hyaluronidase (PEGPH20) Other Phase PHASE1 Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma ClinicalTrials.gov
    Paclitaxel Other Phase PHASE1 Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma ClinicalTrials.gov
    Ramucirumab Other Phase PHASE1 Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma ClinicalTrials.gov
    Testosterone enanthate Other Phase PHASE3 Hypogonadism, Male ClinicalTrials.gov
    rHuPH20 DRUG Phase PHASE2 Dermatitis, Allergic Contact ClinicalTrials.gov
    Humulin-R DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Humalog DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov
    regular human insulin DRUG Phase PHASE2 Diabetes Mellitus, Type 1 ClinicalTrials.gov
    zoledronic acid DRUG Phase PHASE1 Risk Factors for or a Diagnosis of Osteoporosis ClinicalTrials.gov
    hylenex-facilitated subcutaneous Lactated Ringer's infusion DRUG Phase PHASE4 Dehydration ClinicalTrials.gov
    Insulin Lispro Injection DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Insulin Human Injection DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Chemophase DRUG Phase PHASE1 Superficial Bladder Cancer ClinicalTrials.gov
    Liquid meal OTHER Phase PHASE2 Type 1 Diabetes Mellitus ClinicalTrials.gov
    recombinant human hyaluronidase DRUG Phase PHASE4 Dehydration ClinicalTrials.gov
    Hylenex DRUG Phase PHASE3 Pain ClinicalTrials.gov
    IV Ceftriaxone DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    SC Placebo and Ceftriaxone DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    SC HYLENEX and Ceftriaxone DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    hyaluronidase (human recombinant)/rehydration fluid DRUG Phase PHASE4 Dehydration ClinicalTrials.gov
    large protein molecule DRUG Phase PHASE4 Rheumatoid Arthritis ClinicalTrials.gov
    Mitomycin C DRUG Phase PHASE1 Bladder Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: HALOZYME THERAPEUTICS, INC.
    • Ticker Symbol: HALO

Search

News categories